Apollo Hospitals delivers in Q1

In tandem Apollo's healthcare services has doubled its ROCE from FY19 (pre-covid period) to 28% by FY25 thanks to growing in-patient admissions.

- Manish Joshi

Apollo Hospitals Enterprise Ltd shares hit a new 52-week high of ₹7,859.50 on Thursday after surging around 8% the previous day on the back of impressive June quarter (QIFY26) results.

Consolidated net profit jumped 42% year-on-year (y-o-y) to ₹433 crore, with digital health and pharmacy seeing a turnaround. The segment swung to a net profit of ₹57 crore versus a loss of ₹13 crore a year ago on the back of revenue growth and narrowing losses in Apollo 24/7, the digital consultation and treatment business.

In its mainstay healthcare services or hospitals business, Apollo has changed its traditionally reported metric of average revenue per occupied bed (ARPOB) to average revenue per patient (ARPP). Management believes ARPP blends pricing, length of patient stays and occupancy into one figure.